Gerald Garmany

997 total citations · 1 hit paper
10 papers, 731 citations indexed

About

Gerald Garmany is a scholar working on Psychiatry and Mental health, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Gerald Garmany has authored 10 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Psychiatry and Mental health, 1 paper in Molecular Biology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Gerald Garmany's work include Child and Adolescent Health (1 paper), Film in Education and Therapy (1 paper) and Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper). Gerald Garmany is often cited by papers focused on Child and Adolescent Health (1 paper), Film in Education and Therapy (1 paper) and Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper). Gerald Garmany collaborates with scholars based in United Kingdom and United States. Gerald Garmany's co-authors include William Likosky, June Halper, W. H. Stuart, Stanley van den Noort, D. H. Silberberg, Fred Lublin, Douglas S. Goodin, Robert R. Warner and W. Mayer-Groß and has published in prestigious journals such as The Lancet, Neurology and PubMed.

In The Last Decade

Gerald Garmany

10 papers receiving 663 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]

2002 603 citations Douglas S. Goodin, Gerald Garmany et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald Garmany United Kingdom	6	506	194	169	166	111	10	731
D Goodkin United States	10	724 1.4×	221 1.1×	220 1.3×	201 1.2×	131 1.2×	12	1.0k
Rudy Capildeo United Kingdom	13	164 0.3×	273 1.4×	62 0.4×	92 0.6×	110 1.0×	30	853
G V McDonnell United Kingdom	12	444 0.9×	183 0.9×	156 0.9×	74 0.4×	78 0.7×	24	663
Nebojša Stojsavljević Serbia	19	702 1.4×	218 1.1×	257 1.5×	127 0.8×	176 1.6×	34	1.0k
Raeburn B Forbes United Kingdom	17	288 0.6×	475 2.4×	82 0.5×	119 0.7×	148 1.3×	26	1.0k
Bruno Musch United States	12	782 1.5×	615 3.2×	171 1.0×	301 1.8×	136 1.2×	29	1.4k
Adriana Carrá Argentina	12	717 1.4×	320 1.6×	225 1.3×	146 0.9×	141 1.3×	25	822
Mark Wardle United Kingdom	15	585 1.2×	359 1.9×	139 0.8×	124 0.7×	85 0.8×	35	972
J. H. Aarseth Norway	14	335 0.7×	134 0.7×	91 0.5×	63 0.4×	110 1.0×	18	759
Fotini Pittas Australia	15	1.1k 2.1×	128 0.7×	167 1.0×	143 0.9×	354 3.2×	20	1.3k

Countries citing papers authored by Gerald Garmany

Since Specialization

Citations

This map shows the geographic impact of Gerald Garmany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Garmany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Garmany more than expected).

Fields of papers citing papers by Gerald Garmany

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Garmany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Garmany. The network helps show where Gerald Garmany may publish in the future.

Co-authorship network of co-authors of Gerald Garmany

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Garmany. A scholar is included among the top collaborators of Gerald Garmany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Garmany. Gerald Garmany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Goodin, Douglas S., Gerald Garmany, June Halper, et al.. (2002). Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]. Neurology. 58(2). 169–178. 603 indexed citations breakdown →

2.

Garmany, Gerald & Robert R. Warner. (1964). MONOAMINE-OXIDASE INHIBITORS. The Lancet. 283(7339). 932–933. 2 indexed citations

3.

Garmany, Gerald. (1962). Human Behaviour in Illness. By L. Gillis Faber and Faber, 1962. Pp. 214. Price 16s.. Journal of Mental Science. 108(456). 737–737. 5 indexed citations

4.

Garmany, Gerald. (1961). TEACHING PSYCHIATRY TO UNDERGRADUATES*1. The Lancet. 278(7192). 38–40. 9 indexed citations

5.

Garmany, Gerald. (1958). Depressive States: Their Aetiology and Treatment. BMJ. 2(5092). 341–344. 49 indexed citations

6.

Garmany, Gerald. (1956). Anxiety States. BMJ. 1(4973). 943–946. 9 indexed citations

7.

Garmany, Gerald. (1955). Acute Anxiety and Hysteria. BMJ. 2(4931). 115–117. 5 indexed citations

8.

Garmany, Gerald, et al.. (1954). Use and Action of Chlorpromazine in Psychoneuroses. BMJ. 2(4885). 439–441. 42 indexed citations

9.

Garmany, Gerald, et al.. (1953). Discussion on Abreaction. Proceedings of the Royal Society of Medicine. 46(3). 155–162. 5 indexed citations

10.

Mayer-Groß, W., et al.. (1951). Discussion on the treatment of depression.. PubMed. 44(11). 961–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact